(Q46623843)

English

Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A-->G promoter polymorphism

scientific article published in September 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16050950

Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A-->G promoter polymorphism (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16050950

type 2 diabetes

0 references

author name string

Zietz B

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16050950

Büchler C

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16050950

Herfarth H

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16050950

Müller-Ladner U

4

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16050950

Spiegel D

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16050950

Schölmerich J

6

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16050950

Schäffler A

7

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16050950

publication date

1 September 2005

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16050950

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16050950

7

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16050950

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16050950

570-578

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16050950

Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00436.X

21 January 2018

High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00436.X

21 January 2018

Monocyte chemoattractant protein 1 in obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00436.X

21 January 2018

Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00436.X

21 January 2018

Dilazep and fenofibric acid inhibit MCP-1 mRNA expression in glycoxidized LDL-stimulated human endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00436.X

21 January 2018

The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00436.X

21 January 2018

Gly15Gly polymorphism within the human adipocyte-specific apM-1gene but not Tyr111His polymorphism is associated with higher levels of cholesterol and LDL-cholesterol in caucasian patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00436.X

21 January 2018

Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00436.X

21 January 2018

Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00436.X

21 January 2018

Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00436.X

21 January 2018

Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00436.X

21 January 2018

Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00436.X

21 January 2018

Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00436.X

21 January 2018

Nuclear Factor- B Suppressive and Inhibitor- B Stimulatory Effects of Troglitazone in Obese Patients with Type 2 Diabetes: Evidence of an Antiinflammatory Action?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00436.X

21 January 2018

Chemokines control fat accumulation and leptin secretion by cultured human adipocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2004.00436.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2004.00436.X

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16050950

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16050950

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46623843&oldid=2122733753"